Concepedia

Rebecca Moody

RM

6

Publications

167

Citations

6

H-Index

2018

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Center for Drug Evaluation and Research

University of Maryland, Baltimore

Kura Oncology (United States)

Janssen (Belgium)

Rebecca Moody is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacokinetics, and drug discovery.

Top concepts

Publications per year

2018–2025

6

Publications

6

Physiologically Based Biopharmaceutics Modeling (PBBM): Best Practices for Drug Product Quality, Regulatory and Industry Perspectives: 2023 Workshop Summary Report

Claire Mackie, Sumit Arora, Paul Seo et al. · Molecular Pharmaceutics · 2024 · 48 citations · Full text

, , +21

Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer

Chang‐Ching Lin, Miao‐Chia Lo, Rebecca Moody et al. · Cancer Letters · 2018 · 44 citations · Full text

, , +5

Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells

Chang‐Ching Lin, Miao‐Chia Lo, Rebecca Moody et al. · Oncology Reports · 2018 · 26 citations · Full text

Drug Dissolution in Oral Drug Absorption: Workshop Report

Kimberly Raines, Payal Agarwal, Patrick Augustijns et al. · The AAPS Journal · 2023 · 22 citations · Full text

Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report

Christer Tannergren, Sumit Arora, Andrew Babiskin et al. · Molecular Pharmaceutics · 2024 · 16 citations · Full text

Rows per page

1–5 of 6